1. Wenfan Fu, Jian Zhao, Weimin Hu, et al. LINC01224/ZNF91 promote stem cell-like properties and

drive radioresistance in non-small cell lung cancer[J]. Cancer Management and Research, 2021(5671 –

5681).

2. Jian Zhao, Xingyang Xue, Wenfan Fu, et al. Epigenetic activation of FOXF1 confers cancer stem cell

properties to cisplatin-resistant non-small cell lung cancer[J]. International Journal of Oncology, 2020(1083

–1092).

3. Jun Yin, Weimin Hu, Wenfan Fu, et al. HGF/MET regulated epithelial-mesenchymal transitions and

metastasis by FOSL2 in non-small cell lung cancer[J]. OncoTargets and Therapy, 2019(9227

–

9237).

4. Jun Yin, Weimin Hu, Xingyang Xue, et al. Epigenetic activation of hepatocyte growth factor is

6. Jun Yin, Wenfan Fu, Lu Dai, et al. ANKRD22 promotes progression of non-small cell lung cancer

through transcriptional up-regulation of E2F1[J]. Scientific Reports, 2017(4430).

7. Jun Yin, Wei Luo, Xiang Zeng, et al. UXT-AS1-induced alternative splicing of UXT is associated

with tumor progression in colorectal cancer[J]. American Journal of Cancer Research, 2017(462–472).

8. Jun Yin, Jian Zhao, Weimin Hu, et al. Disturbance of the let-7/LIN28 double-negative feedback loop

is associated with radio- and chemo-resistance in non-small cell lung cancer[J]. PLoS ONE,

2017(e0172787).

9. Jian Zhao, Wenfan Fu, Hongying Liao, et al. The regulatory and predictive functions of miR-17 and

miR-92 families on cisplatin resistance of non-small cell lung cancer[J]. BMC Cancer, 2015(731).

10. Jun Yin, Xianggao Meng, Shibing Zhang, et al. The effect of a nuclear localization sequence on